nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—CYP2C9—Loratadine—atopic dermatitis	0.0341	0.426	CbGbCtD
Epoprostenol—CYP2C9—Diphenhydramine—atopic dermatitis	0.0341	0.426	CbGbCtD
Epoprostenol—CYP2C9—Dexamethasone—atopic dermatitis	0.0118	0.148	CbGbCtD
Epoprostenol—P2RY12—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00149	0.00878	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—NPS—atopic dermatitis	0.00147	0.00864	CbGpPWpGaD
Epoprostenol—PTGER1—G alpha (q) signalling events—TAC1—atopic dermatitis	0.00147	0.00864	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00145	0.00856	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CCL27—atopic dermatitis	0.00141	0.0083	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CCL27—atopic dermatitis	0.00141	0.0083	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00138	0.00814	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CCL17—atopic dermatitis	0.00137	0.00809	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00134	0.00788	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00134	0.00788	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00131	0.00773	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00131	0.00773	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.0013	0.00767	CbGpPWpGaD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—IL5—atopic dermatitis	0.0013	0.00764	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00127	0.0075	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00127	0.0075	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CCL17—atopic dermatitis	0.00126	0.00744	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CCL17—atopic dermatitis	0.00126	0.00744	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00121	0.00712	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00119	0.00698	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00111	0.00655	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00111	0.00655	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CCL11—atopic dermatitis	0.00111	0.00652	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—KIF3A—atopic dermatitis	0.0011	0.00645	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00109	0.00642	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00109	0.00642	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00106	0.00622	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00106	0.00622	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00105	0.0062	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00104	0.0061	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CCL11—atopic dermatitis	0.00102	0.006	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CCL11—atopic dermatitis	0.00102	0.006	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—KIF3A—atopic dermatitis	0.00101	0.00593	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000973	0.00572	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000973	0.00572	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000973	0.00572	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000973	0.00572	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000954	0.00561	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000954	0.00561	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000907	0.00534	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CCR3—atopic dermatitis	0.000903	0.00531	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—SELE—atopic dermatitis	0.000883	0.0052	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCL22—atopic dermatitis	0.000882	0.00519	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CCL27—atopic dermatitis	0.000866	0.0051	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000838	0.00493	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CCR3—atopic dermatitis	0.000831	0.00489	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CCR3—atopic dermatitis	0.000831	0.00489	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000817	0.00481	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—SELE—atopic dermatitis	0.000812	0.00478	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCL22—atopic dermatitis	0.000812	0.00478	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCL22—atopic dermatitis	0.000812	0.00478	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—NPS—atopic dermatitis	0.000805	0.00474	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—TAC1—atopic dermatitis	0.000805	0.00474	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000797	0.00469	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CCL27—atopic dermatitis	0.000797	0.00469	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—GLB1—atopic dermatitis	0.000796	0.00468	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CXCR3—atopic dermatitis	0.000789	0.00464	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCL27—atopic dermatitis	0.000786	0.00463	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000771	0.00454	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000771	0.00454	CbGpPWpGaD
Epoprostenol—P2RY12—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000758	0.00446	CbGpPWpGaD
Epoprostenol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000747	0.0044	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—NPS—atopic dermatitis	0.000741	0.00436	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—NPS—atopic dermatitis	0.000741	0.00436	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—TAC1—atopic dermatitis	0.000741	0.00436	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—TAC1—atopic dermatitis	0.000741	0.00436	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CXCR3—atopic dermatitis	0.000726	0.00427	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000726	0.00427	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCL27—atopic dermatitis	0.000724	0.00426	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCL27—atopic dermatitis	0.000724	0.00426	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000721	0.00424	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCL17—atopic dermatitis	0.000705	0.00415	CbGpPWpGaD
Epoprostenol—PTGER1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000698	0.00411	CbGpPWpGaD
Epoprostenol—PTGIR—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000698	0.00411	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—TNF—atopic dermatitis	0.000694	0.00409	CbGpPWpGaD
Epoprostenol—P2RY12—Hemostasis—IL5—atopic dermatitis	0.000669	0.00394	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—GLB1—atopic dermatitis	0.000666	0.00392	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000664	0.00391	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000664	0.00391	CbGpPWpGaD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00065	0.00382	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCL17—atopic dermatitis	0.000649	0.00382	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCL17—atopic dermatitis	0.000649	0.00382	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—ADSL—atopic dermatitis	0.000639	0.00376	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR ligand binding—CXCL10—atopic dermatitis	0.000638	0.00375	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—IL5—atopic dermatitis	0.000616	0.00362	CbGpPWpGaD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000598	0.00352	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000598	0.00352	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CXCL10—atopic dermatitis	0.000587	0.00346	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000587	0.00346	CbGpPWpGaD
Epoprostenol—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000574	0.000765	CcSEcCtD
Epoprostenol—Weight decreased—Prednisone—atopic dermatitis	0.00057	0.00076	CcSEcCtD
Epoprostenol—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000569	0.000758	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—CCL11—atopic dermatitis	0.000568	0.00335	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—FCER2—atopic dermatitis	0.00056	0.0033	CbGpPWpGaD
Epoprostenol—PTGIS—Adipogenesis—IL6—atopic dermatitis	0.00056	0.0033	CbGpPWpGaD
Epoprostenol—Depression—Prednisone—atopic dermatitis	0.00056	0.000747	CcSEcCtD
Epoprostenol—Mental disorder—Methylprednisolone—atopic dermatitis	0.000558	0.000744	CcSEcCtD
Epoprostenol—Asthenia—Tacrolimus—atopic dermatitis	0.000554	0.000738	CcSEcCtD
Epoprostenol—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000554	0.000738	CcSEcCtD
Epoprostenol—Myocardial infarction—Prednisone—atopic dermatitis	0.000551	0.000734	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—CCL5—atopic dermatitis	0.000549	0.00323	CbGpPWpGaD
Epoprostenol—Pruritus—Tacrolimus—atopic dermatitis	0.000546	0.000728	CcSEcCtD
Epoprostenol—Syncope—Prednisolone—atopic dermatitis	0.000542	0.000722	CcSEcCtD
Epoprostenol—Back pain—Triamcinolone—atopic dermatitis	0.000537	0.000716	CcSEcCtD
Epoprostenol—PTGIS—Disease—SLC11A1—atopic dermatitis	0.000533	0.00314	CbGpPWpGaD
Epoprostenol—Loss of consciousness—Prednisolone—atopic dermatitis	0.000531	0.000708	CcSEcCtD
Epoprostenol—Syncope—Hydrocortisone—atopic dermatitis	0.000529	0.000705	CcSEcCtD
Epoprostenol—Diarrhoea—Tacrolimus—atopic dermatitis	0.000528	0.000704	CcSEcCtD
Epoprostenol—Angiopathy—Dexamethasone—atopic dermatitis	0.000525	0.0007	CcSEcCtD
Epoprostenol—Angiopathy—Betamethasone—atopic dermatitis	0.000525	0.0007	CcSEcCtD
Epoprostenol—PTGIR—Signaling by GPCR—CCL11—atopic dermatitis	0.000523	0.00308	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCL11—atopic dermatitis	0.000523	0.00308	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL22—atopic dermatitis	0.000521	0.00307	CbGpPWpGaD
Epoprostenol—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000519	0.000691	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—FCER2—atopic dermatitis	0.000516	0.00304	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—FCER2—atopic dermatitis	0.000516	0.00304	CbGpPWpGaD
Epoprostenol—Bradycardia—Prednisone—atopic dermatitis	0.000513	0.000684	CcSEcCtD
Epoprostenol—Dizziness—Tacrolimus—atopic dermatitis	0.00051	0.000681	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—CCR3—atopic dermatitis	0.00051	0.003	CbGpPWpGaD
Epoprostenol—Haemoglobin—Prednisone—atopic dermatitis	0.000507	0.000676	CcSEcCtD
Epoprostenol—PTGER1—GPCR ligand binding—CCL5—atopic dermatitis	0.000505	0.00297	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CCL5—atopic dermatitis	0.000505	0.00297	CbGpPWpGaD
Epoprostenol—Haemorrhage—Prednisone—atopic dermatitis	0.000504	0.000672	CcSEcCtD
Epoprostenol—Myalgia—Hydrocortisone—atopic dermatitis	0.000502	0.00067	CcSEcCtD
Epoprostenol—Anxiety—Hydrocortisone—atopic dermatitis	0.000501	0.000667	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000499	0.000665	CcSEcCtD
Epoprostenol—Syncope—Triamcinolone—atopic dermatitis	0.000498	0.000664	CcSEcCtD
Epoprostenol—Syncope—Methylprednisolone—atopic dermatitis	0.000497	0.000663	CcSEcCtD
Epoprostenol—P2RY12—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	0.000496	0.00292	CbGpPWpGaD
Epoprostenol—Connective tissue disorder—Prednisone—atopic dermatitis	0.000496	0.000661	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—CCR5—atopic dermatitis	0.000495	0.00291	CbGpPWpGaD
Epoprostenol—P2RY12—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.000494	0.00291	CbGpPWpGaD
Epoprostenol—Oedema—Prednisolone—atopic dermatitis	0.000493	0.000657	CcSEcCtD
Epoprostenol—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000493	0.000657	CcSEcCtD
Epoprostenol—Vomiting—Tacrolimus—atopic dermatitis	0.000491	0.000654	CcSEcCtD
Epoprostenol—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000488	0.000651	CcSEcCtD
Epoprostenol—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000487	0.00065	CcSEcCtD
Epoprostenol—Rash—Tacrolimus—atopic dermatitis	0.000487	0.000649	CcSEcCtD
Epoprostenol—Dermatitis—Tacrolimus—atopic dermatitis	0.000486	0.000648	CcSEcCtD
Epoprostenol—PTGIS—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000485	0.00286	CbGpPWpGaD
Epoprostenol—Shock—Prednisolone—atopic dermatitis	0.000485	0.000647	CcSEcCtD
Epoprostenol—Cough—Triamcinolone—atopic dermatitis	0.000485	0.000646	CcSEcCtD
Epoprostenol—Headache—Tacrolimus—atopic dermatitis	0.000484	0.000645	CcSEcCtD
Epoprostenol—Oedema—Hydrocortisone—atopic dermatitis	0.000482	0.000642	CcSEcCtD
Epoprostenol—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000482	0.000642	CcSEcCtD
Epoprostenol—Tachycardia—Prednisolone—atopic dermatitis	0.000481	0.000642	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—CCL22—atopic dermatitis	0.00048	0.00282	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL22—atopic dermatitis	0.00048	0.00282	CbGpPWpGaD
Epoprostenol—Infection—Hydrocortisone—atopic dermatitis	0.000478	0.000638	CcSEcCtD
Epoprostenol—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000477	0.000635	CcSEcCtD
Epoprostenol—Shock—Hydrocortisone—atopic dermatitis	0.000474	0.000632	CcSEcCtD
Epoprostenol—Myalgia—Triamcinolone—atopic dermatitis	0.000473	0.000631	CcSEcCtD
Epoprostenol—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000472	0.00063	CcSEcCtD
Epoprostenol—Myalgia—Methylprednisolone—atopic dermatitis	0.000472	0.000629	CcSEcCtD
Epoprostenol—Arthralgia—Methylprednisolone—atopic dermatitis	0.000472	0.000629	CcSEcCtD
Epoprostenol—Anxiety—Methylprednisolone—atopic dermatitis	0.00047	0.000627	CcSEcCtD
Epoprostenol—Tachycardia—Hydrocortisone—atopic dermatitis	0.00047	0.000627	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—CCR3—atopic dermatitis	0.00047	0.00276	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CCR3—atopic dermatitis	0.00047	0.00276	CbGpPWpGaD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000469	0.000625	CcSEcCtD
Epoprostenol—Flushing—Prednisone—atopic dermatitis	0.000468	0.000624	CcSEcCtD
Epoprostenol—Skin disorder—Hydrocortisone—atopic dermatitis	0.000468	0.000624	CcSEcCtD
Epoprostenol—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000465	0.000621	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—CCL27—atopic dermatitis	0.000464	0.00273	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCR3—atopic dermatitis	0.000463	0.00273	CbGpPWpGaD
Epoprostenol—Dry mouth—Triamcinolone—atopic dermatitis	0.000463	0.000617	CcSEcCtD
Epoprostenol—Anorexia—Hydrocortisone—atopic dermatitis	0.000459	0.000612	CcSEcCtD
Epoprostenol—Nausea—Tacrolimus—atopic dermatitis	0.000458	0.000611	CcSEcCtD
Epoprostenol—Angiopathy—Prednisone—atopic dermatitis	0.000458	0.00061	CcSEcCtD
Epoprostenol—Confusional state—Methylprednisolone—atopic dermatitis	0.000456	0.000608	CcSEcCtD
Epoprostenol—PTGER1—GPCR ligand binding—CCR5—atopic dermatitis	0.000455	0.00268	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CCR5—atopic dermatitis	0.000455	0.00268	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—TAC1—atopic dermatitis	0.000455	0.00268	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—NPS—atopic dermatitis	0.000455	0.00268	CbGpPWpGaD
Epoprostenol—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000453	0.000604	CcSEcCtD
Epoprostenol—Oedema—Triamcinolone—atopic dermatitis	0.000453	0.000604	CcSEcCtD
Epoprostenol—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000452	0.000603	CcSEcCtD
Epoprostenol—Syncope—Betamethasone—atopic dermatitis	0.000452	0.000603	CcSEcCtD
Epoprostenol—Syncope—Dexamethasone—atopic dermatitis	0.000452	0.000603	CcSEcCtD
Epoprostenol—Infection—Triamcinolone—atopic dermatitis	0.00045	0.000601	CcSEcCtD
Epoprostenol—Hypotension—Hydrocortisone—atopic dermatitis	0.00045	0.0006	CcSEcCtD
Epoprostenol—Infection—Methylprednisolone—atopic dermatitis	0.000449	0.000599	CcSEcCtD
Epoprostenol—Shock—Triamcinolone—atopic dermatitis	0.000446	0.000595	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000446	0.00262	CbGpPWpGaD
Epoprostenol—Insomnia—Prednisolone—atopic dermatitis	0.000446	0.000595	CcSEcCtD
Epoprostenol—Shock—Methylprednisolone—atopic dermatitis	0.000445	0.000593	CcSEcCtD
Epoprostenol—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000444	0.000591	CcSEcCtD
Epoprostenol—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000443	0.000591	CcSEcCtD
Epoprostenol—Loss of consciousness—Betamethasone—atopic dermatitis	0.000443	0.000591	CcSEcCtD
Epoprostenol—Paraesthesia—Prednisolone—atopic dermatitis	0.000443	0.00059	CcSEcCtD
Epoprostenol—Tachycardia—Triamcinolone—atopic dermatitis	0.000442	0.00059	CcSEcCtD
Epoprostenol—Mental disorder—Prednisone—atopic dermatitis	0.000442	0.000589	CcSEcCtD
Epoprostenol—Tachycardia—Methylprednisolone—atopic dermatitis	0.000442	0.000589	CcSEcCtD
Epoprostenol—Skin disorder—Methylprednisolone—atopic dermatitis	0.000439	0.000586	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000439	0.000585	CcSEcCtD
Epoprostenol—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000438	0.000584	CcSEcCtD
Epoprostenol—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000437	0.000583	CcSEcCtD
Epoprostenol—Insomnia—Hydrocortisone—atopic dermatitis	0.000435	0.000581	CcSEcCtD
Epoprostenol—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000432	0.000576	CcSEcCtD
Epoprostenol—Myalgia—Betamethasone—atopic dermatitis	0.000429	0.000572	CcSEcCtD
Epoprostenol—Myalgia—Dexamethasone—atopic dermatitis	0.000429	0.000572	CcSEcCtD
Epoprostenol—Anxiety—Dexamethasone—atopic dermatitis	0.000428	0.00057	CcSEcCtD
Epoprostenol—Anxiety—Betamethasone—atopic dermatitis	0.000428	0.00057	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—CCL27—atopic dermatitis	0.000427	0.00252	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL27—atopic dermatitis	0.000427	0.00252	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCR3—atopic dermatitis	0.000426	0.00251	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCR3—atopic dermatitis	0.000426	0.00251	CbGpPWpGaD
Epoprostenol—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000424	0.000565	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—IL5—atopic dermatitis	0.000423	0.00249	CbGpPWpGaD
Epoprostenol—Hypotension—Methylprednisolone—atopic dermatitis	0.000423	0.000564	CcSEcCtD
Epoprostenol—Pain—Prednisolone—atopic dermatitis	0.000422	0.000562	CcSEcCtD
Epoprostenol—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000419	0.000558	CcSEcCtD
Epoprostenol—PTGIR—GPCR downstream signaling—TAC1—atopic dermatitis	0.000419	0.00246	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—NPS—atopic dermatitis	0.000419	0.00246	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000419	0.00246	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—NPS—atopic dermatitis	0.000419	0.00246	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL17—atopic dermatitis	0.000417	0.00245	CbGpPWpGaD
Epoprostenol—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000416	0.000554	CcSEcCtD
Epoprostenol—Fatigue—Hydrocortisone—atopic dermatitis	0.000415	0.000553	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000413	0.000551	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—TAC1—atopic dermatitis	0.000413	0.00243	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—NPS—atopic dermatitis	0.000413	0.00243	CbGpPWpGaD
Epoprostenol—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000412	0.00055	CcSEcCtD
Epoprostenol—Pain—Hydrocortisone—atopic dermatitis	0.000412	0.000549	CcSEcCtD
Epoprostenol—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000411	0.000548	CcSEcCtD
Epoprostenol—Oedema—Dexamethasone—atopic dermatitis	0.000411	0.000548	CcSEcCtD
Epoprostenol—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000411	0.000548	CcSEcCtD
Epoprostenol—Oedema—Betamethasone—atopic dermatitis	0.000411	0.000548	CcSEcCtD
Epoprostenol—PTGIR—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00041	0.00242	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00041	0.00242	CbGpPWpGaD
Epoprostenol—Insomnia—Triamcinolone—atopic dermatitis	0.00041	0.000547	CcSEcCtD
Epoprostenol—Insomnia—Methylprednisolone—atopic dermatitis	0.000409	0.000546	CcSEcCtD
Epoprostenol—Infection—Betamethasone—atopic dermatitis	0.000409	0.000545	CcSEcCtD
Epoprostenol—Infection—Dexamethasone—atopic dermatitis	0.000409	0.000545	CcSEcCtD
Epoprostenol—Paraesthesia—Triamcinolone—atopic dermatitis	0.000407	0.000543	CcSEcCtD
Epoprostenol—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000406	0.000542	CcSEcCtD
Epoprostenol—Anaemia—Prednisone—atopic dermatitis	0.000406	0.000541	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—CXCR3—atopic dermatitis	0.000405	0.00238	CbGpPWpGaD
Epoprostenol—Shock—Dexamethasone—atopic dermatitis	0.000405	0.00054	CcSEcCtD
Epoprostenol—Shock—Betamethasone—atopic dermatitis	0.000405	0.00054	CcSEcCtD
Epoprostenol—Dyspnoea—Triamcinolone—atopic dermatitis	0.000404	0.000539	CcSEcCtD
Epoprostenol—Nervous system disorder—Betamethasone—atopic dermatitis	0.000403	0.000538	CcSEcCtD
Epoprostenol—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000403	0.000538	CcSEcCtD
Epoprostenol—Agitation—Prednisone—atopic dermatitis	0.000403	0.000538	CcSEcCtD
Epoprostenol—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000403	0.000537	CcSEcCtD
Epoprostenol—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000403	0.000537	CcSEcCtD
Epoprostenol—Tachycardia—Betamethasone—atopic dermatitis	0.000401	0.000535	CcSEcCtD
Epoprostenol—Tachycardia—Dexamethasone—atopic dermatitis	0.000401	0.000535	CcSEcCtD
Epoprostenol—Dyspepsia—Triamcinolone—atopic dermatitis	0.000399	0.000532	CcSEcCtD
Epoprostenol—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000398	0.000531	CcSEcCtD
Epoprostenol—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000398	0.00053	CcSEcCtD
Epoprostenol—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000398	0.00053	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000394	0.000525	CcSEcCtD
Epoprostenol—Syncope—Prednisone—atopic dermatitis	0.000394	0.000525	CcSEcCtD
Epoprostenol—P2RY12—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000393	0.00231	CbGpPWpGaD
Epoprostenol—Anorexia—Betamethasone—atopic dermatitis	0.000392	0.000523	CcSEcCtD
Epoprostenol—Anorexia—Dexamethasone—atopic dermatitis	0.000392	0.000523	CcSEcCtD
Epoprostenol—Urticaria—Prednisolone—atopic dermatitis	0.000392	0.000522	CcSEcCtD
Epoprostenol—Fatigue—Triamcinolone—atopic dermatitis	0.000391	0.000521	CcSEcCtD
Epoprostenol—Fatigue—Methylprednisolone—atopic dermatitis	0.00039	0.00052	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—IL5—atopic dermatitis	0.000389	0.00229	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—IL5—atopic dermatitis	0.000389	0.00229	CbGpPWpGaD
Epoprostenol—Pain—Triamcinolone—atopic dermatitis	0.000388	0.000517	CcSEcCtD
Epoprostenol—Loss of consciousness—Prednisone—atopic dermatitis	0.000386	0.000514	CcSEcCtD
Epoprostenol—Hypotension—Betamethasone—atopic dermatitis	0.000384	0.000513	CcSEcCtD
Epoprostenol—Hypotension—Dexamethasone—atopic dermatitis	0.000384	0.000513	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—IL5—atopic dermatitis	0.000384	0.00226	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL17—atopic dermatitis	0.000383	0.00226	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCL17—atopic dermatitis	0.000383	0.00226	CbGpPWpGaD
Epoprostenol—Urticaria—Hydrocortisone—atopic dermatitis	0.000383	0.00051	CcSEcCtD
Epoprostenol—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000381	0.000507	CcSEcCtD
Epoprostenol—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000381	0.000507	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—NPS—atopic dermatitis	0.00038	0.00224	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—TAC1—atopic dermatitis	0.00038	0.00224	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—TAC1—atopic dermatitis	0.00038	0.00224	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—NPS—atopic dermatitis	0.00038	0.00224	CbGpPWpGaD
Epoprostenol—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000375	0.0005	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000375	0.0005	CcSEcCtD
Epoprostenol—Arthralgia—Prednisone—atopic dermatitis	0.000374	0.000498	CcSEcCtD
Epoprostenol—Myalgia—Prednisone—atopic dermatitis	0.000374	0.000498	CcSEcCtD
Epoprostenol—PTGIR—Signaling by GPCR—CXCR3—atopic dermatitis	0.000373	0.00219	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000373	0.00219	CbGpPWpGaD
Epoprostenol—Anxiety—Prednisone—atopic dermatitis	0.000372	0.000497	CcSEcCtD
Epoprostenol—Insomnia—Betamethasone—atopic dermatitis	0.000372	0.000496	CcSEcCtD
Epoprostenol—Insomnia—Dexamethasone—atopic dermatitis	0.000372	0.000496	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—KIF3A—atopic dermatitis	0.000371	0.00219	CbGpPWpGaD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000371	0.000495	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.00037	0.000493	CcSEcCtD
Epoprostenol—Paraesthesia—Dexamethasone—atopic dermatitis	0.000369	0.000493	CcSEcCtD
Epoprostenol—Paraesthesia—Betamethasone—atopic dermatitis	0.000369	0.000493	CcSEcCtD
Epoprostenol—Hypersensitivity—Prednisolone—atopic dermatitis	0.000363	0.000484	CcSEcCtD
Epoprostenol—Dyspepsia—Betamethasone—atopic dermatitis	0.000362	0.000483	CcSEcCtD
Epoprostenol—Dyspepsia—Dexamethasone—atopic dermatitis	0.000362	0.000483	CcSEcCtD
Epoprostenol—PTGIR—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000361	0.00213	CbGpPWpGaD
Epoprostenol—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000361	0.00213	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00036	0.00212	CbGpPWpGaD
Epoprostenol—Urticaria—Triamcinolone—atopic dermatitis	0.00036	0.00048	CcSEcCtD
Epoprostenol—Urticaria—Methylprednisolone—atopic dermatitis	0.000359	0.000479	CcSEcCtD
Epoprostenol—Body temperature increased—Triamcinolone—atopic dermatitis	0.000358	0.000478	CcSEcCtD
Epoprostenol—Anaphylactic shock—Prednisone—atopic dermatitis	0.000358	0.000478	CcSEcCtD
Epoprostenol—Oedema—Prednisone—atopic dermatitis	0.000358	0.000478	CcSEcCtD
Epoprostenol—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000358	0.000477	CcSEcCtD
Epoprostenol—Decreased appetite—Betamethasone—atopic dermatitis	0.000358	0.000477	CcSEcCtD
Epoprostenol—Decreased appetite—Dexamethasone—atopic dermatitis	0.000358	0.000477	CcSEcCtD
Epoprostenol—Infection—Prednisone—atopic dermatitis	0.000356	0.000475	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000355	0.000474	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000355	0.000474	CcSEcCtD
Epoprostenol—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000355	0.000473	CcSEcCtD
Epoprostenol—Fatigue—Betamethasone—atopic dermatitis	0.000355	0.000473	CcSEcCtD
Epoprostenol—Fatigue—Dexamethasone—atopic dermatitis	0.000355	0.000473	CcSEcCtD
Epoprostenol—PTGER1—Signaling by GPCR—IL5—atopic dermatitis	0.000353	0.00208	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL5—atopic dermatitis	0.000353	0.00208	CbGpPWpGaD
Epoprostenol—Shock—Prednisone—atopic dermatitis	0.000352	0.00047	CcSEcCtD
Epoprostenol—Pain—Betamethasone—atopic dermatitis	0.000352	0.000469	CcSEcCtD
Epoprostenol—Pain—Dexamethasone—atopic dermatitis	0.000352	0.000469	CcSEcCtD
Epoprostenol—Nervous system disorder—Prednisone—atopic dermatitis	0.000351	0.000468	CcSEcCtD
Epoprostenol—Tachycardia—Prednisone—atopic dermatitis	0.00035	0.000466	CcSEcCtD
Epoprostenol—Skin disorder—Prednisone—atopic dermatitis	0.000348	0.000464	CcSEcCtD
Epoprostenol—Hyperhidrosis—Prednisone—atopic dermatitis	0.000346	0.000462	CcSEcCtD
Epoprostenol—Asthenia—Hydrocortisone—atopic dermatitis	0.000345	0.000461	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—KIF3A—atopic dermatitis	0.000342	0.00201	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—KIF3A—atopic dermatitis	0.000342	0.00201	CbGpPWpGaD
Epoprostenol—Anorexia—Prednisone—atopic dermatitis	0.000341	0.000455	CcSEcCtD
Epoprostenol—Pruritus—Hydrocortisone—atopic dermatitis	0.000341	0.000454	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000336	0.000449	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000336	0.000449	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—CMA1—atopic dermatitis	0.000336	0.00198	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL11—atopic dermatitis	0.000336	0.00198	CbGpPWpGaD
Epoprostenol—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000334	0.000445	CcSEcCtD
Epoprostenol—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000333	0.000444	CcSEcCtD
Epoprostenol—PTGIR—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000332	0.00195	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000332	0.00195	CbGpPWpGaD
Epoprostenol—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000329	0.000439	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—CXCL10—atopic dermatitis	0.000327	0.00193	CbGpPWpGaD
Epoprostenol—Urticaria—Dexamethasone—atopic dermatitis	0.000327	0.000436	CcSEcCtD
Epoprostenol—Urticaria—Betamethasone—atopic dermatitis	0.000327	0.000436	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000326	0.000435	CcSEcCtD
Epoprostenol—Dizziness—Prednisolone—atopic dermatitis	0.000326	0.000435	CcSEcCtD
Epoprostenol—Asthenia—Triamcinolone—atopic dermatitis	0.000325	0.000434	CcSEcCtD
Epoprostenol—Abdominal pain—Dexamethasone—atopic dermatitis	0.000325	0.000434	CcSEcCtD
Epoprostenol—Abdominal pain—Betamethasone—atopic dermatitis	0.000325	0.000434	CcSEcCtD
Epoprostenol—Body temperature increased—Dexamethasone—atopic dermatitis	0.000325	0.000434	CcSEcCtD
Epoprostenol—Body temperature increased—Betamethasone—atopic dermatitis	0.000325	0.000434	CcSEcCtD
Epoprostenol—Asthenia—Methylprednisolone—atopic dermatitis	0.000325	0.000433	CcSEcCtD
Epoprostenol—Insomnia—Prednisone—atopic dermatitis	0.000324	0.000432	CcSEcCtD
Epoprostenol—Paraesthesia—Prednisone—atopic dermatitis	0.000322	0.000429	CcSEcCtD
Epoprostenol—Pruritus—Triamcinolone—atopic dermatitis	0.000321	0.000428	CcSEcCtD
Epoprostenol—Pruritus—Methylprednisolone—atopic dermatitis	0.00032	0.000427	CcSEcCtD
Epoprostenol—Dizziness—Hydrocortisone—atopic dermatitis	0.000318	0.000425	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—STAT6—atopic dermatitis	0.000316	0.00186	CbGpPWpGaD
Epoprostenol—Dyspepsia—Prednisone—atopic dermatitis	0.000315	0.00042	CcSEcCtD
Epoprostenol—Decreased appetite—Prednisone—atopic dermatitis	0.000311	0.000415	CcSEcCtD
Epoprostenol—Rash—Prednisolone—atopic dermatitis	0.000311	0.000414	CcSEcCtD
Epoprostenol—Dermatitis—Prednisolone—atopic dermatitis	0.000311	0.000414	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—CCL5—atopic dermatitis	0.00031	0.00183	CbGpPWpGaD
Epoprostenol—Diarrhoea—Methylprednisolone—atopic dermatitis	0.00031	0.000413	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—CCL11—atopic dermatitis	0.000309	0.00182	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL11—atopic dermatitis	0.000309	0.00182	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CMA1—atopic dermatitis	0.000309	0.00182	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CMA1—atopic dermatitis	0.000309	0.00182	CbGpPWpGaD
Epoprostenol—Fatigue—Prednisone—atopic dermatitis	0.000309	0.000412	CcSEcCtD
Epoprostenol—Headache—Prednisolone—atopic dermatitis	0.000309	0.000412	CcSEcCtD
Epoprostenol—Constipation—Prednisone—atopic dermatitis	0.000306	0.000408	CcSEcCtD
Epoprostenol—Vomiting—Hydrocortisone—atopic dermatitis	0.000306	0.000408	CcSEcCtD
Epoprostenol—Rash—Hydrocortisone—atopic dermatitis	0.000304	0.000405	CcSEcCtD
Epoprostenol—Dermatitis—Hydrocortisone—atopic dermatitis	0.000303	0.000404	CcSEcCtD
Epoprostenol—Headache—Hydrocortisone—atopic dermatitis	0.000302	0.000402	CcSEcCtD
Epoprostenol—PTGIR—Signaling by GPCR—CXCL10—atopic dermatitis	0.000301	0.00177	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000301	0.00177	CbGpPWpGaD
Epoprostenol—Dizziness—Triamcinolone—atopic dermatitis	0.0003	0.0004	CcSEcCtD
Epoprostenol—Dizziness—Methylprednisolone—atopic dermatitis	0.000299	0.000399	CcSEcCtD
Epoprostenol—P2RY12—GPCR ligand binding—CXCL8—atopic dermatitis	0.000299	0.00176	CbGpPWpGaD
Epoprostenol—Asthenia—Betamethasone—atopic dermatitis	0.000295	0.000394	CcSEcCtD
Epoprostenol—Asthenia—Dexamethasone—atopic dermatitis	0.000295	0.000394	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000293	0.000391	CcSEcCtD
Epoprostenol—Nausea—Prednisolone—atopic dermatitis	0.000293	0.00039	CcSEcCtD
Epoprostenol—Pruritus—Betamethasone—atopic dermatitis	0.000291	0.000388	CcSEcCtD
Epoprostenol—Pruritus—Dexamethasone—atopic dermatitis	0.000291	0.000388	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—STAT6—atopic dermatitis	0.000291	0.00171	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—STAT6—atopic dermatitis	0.000291	0.00171	CbGpPWpGaD
Epoprostenol—Vomiting—Triamcinolone—atopic dermatitis	0.000288	0.000384	CcSEcCtD
Epoprostenol—Vomiting—Methylprednisolone—atopic dermatitis	0.000288	0.000383	CcSEcCtD
Epoprostenol—Nausea—Hydrocortisone—atopic dermatitis	0.000286	0.000381	CcSEcCtD
Epoprostenol—Rash—Triamcinolone—atopic dermatitis	0.000286	0.000381	CcSEcCtD
Epoprostenol—Dermatitis—Triamcinolone—atopic dermatitis	0.000286	0.000381	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000286	0.00168	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CCL5—atopic dermatitis	0.000286	0.00168	CbGpPWpGaD
Epoprostenol—Rash—Methylprednisolone—atopic dermatitis	0.000285	0.00038	CcSEcCtD
Epoprostenol—Dermatitis—Methylprednisolone—atopic dermatitis	0.000285	0.00038	CcSEcCtD
Epoprostenol—Urticaria—Prednisone—atopic dermatitis	0.000285	0.000379	CcSEcCtD
Epoprostenol—Headache—Triamcinolone—atopic dermatitis	0.000284	0.000379	CcSEcCtD
Epoprostenol—Headache—Methylprednisolone—atopic dermatitis	0.000283	0.000378	CcSEcCtD
Epoprostenol—Abdominal pain—Prednisone—atopic dermatitis	0.000283	0.000378	CcSEcCtD
Epoprostenol—Body temperature increased—Prednisone—atopic dermatitis	0.000283	0.000378	CcSEcCtD
Epoprostenol—P2RY12—Signaling by GPCR—CCL5—atopic dermatitis	0.000282	0.00166	CbGpPWpGaD
Epoprostenol—Diarrhoea—Betamethasone—atopic dermatitis	0.000281	0.000375	CcSEcCtD
Epoprostenol—Diarrhoea—Dexamethasone—atopic dermatitis	0.000281	0.000375	CcSEcCtD
Epoprostenol—P2RY12—GPCR downstream signaling—CCR5—atopic dermatitis	0.00028	0.00165	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000275	0.00162	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR ligand binding—CXCL8—atopic dermatitis	0.000275	0.00162	CbGpPWpGaD
Epoprostenol—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000274	0.00161	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCR3—atopic dermatitis	0.000274	0.00161	CbGpPWpGaD
Epoprostenol—Dizziness—Dexamethasone—atopic dermatitis	0.000272	0.000363	CcSEcCtD
Epoprostenol—Dizziness—Betamethasone—atopic dermatitis	0.000272	0.000363	CcSEcCtD
Epoprostenol—Nausea—Triamcinolone—atopic dermatitis	0.000269	0.000359	CcSEcCtD
Epoprostenol—PTGIS—Disease—CCR5—atopic dermatitis	0.000269	0.00158	CbGpPWpGaD
Epoprostenol—Nausea—Methylprednisolone—atopic dermatitis	0.000269	0.000358	CcSEcCtD
Epoprostenol—Hypersensitivity—Prednisone—atopic dermatitis	0.000264	0.000352	CcSEcCtD
Epoprostenol—Vomiting—Dexamethasone—atopic dermatitis	0.000262	0.000349	CcSEcCtD
Epoprostenol—Vomiting—Betamethasone—atopic dermatitis	0.000262	0.000349	CcSEcCtD
Epoprostenol—Rash—Betamethasone—atopic dermatitis	0.000259	0.000346	CcSEcCtD
Epoprostenol—Rash—Dexamethasone—atopic dermatitis	0.000259	0.000346	CcSEcCtD
Epoprostenol—PTGIR—Signaling by GPCR—CCL5—atopic dermatitis	0.000259	0.00153	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCL5—atopic dermatitis	0.000259	0.00153	CbGpPWpGaD
Epoprostenol—Dermatitis—Betamethasone—atopic dermatitis	0.000259	0.000346	CcSEcCtD
Epoprostenol—Dermatitis—Dexamethasone—atopic dermatitis	0.000259	0.000346	CcSEcCtD
Epoprostenol—Headache—Dexamethasone—atopic dermatitis	0.000258	0.000344	CcSEcCtD
Epoprostenol—Headache—Betamethasone—atopic dermatitis	0.000258	0.000344	CcSEcCtD
Epoprostenol—PTGER1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000257	0.00151	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CCR5—atopic dermatitis	0.000257	0.00151	CbGpPWpGaD
Epoprostenol—Asthenia—Prednisone—atopic dermatitis	0.000257	0.000343	CcSEcCtD
Epoprostenol—P2RY12—Hemostasis—IL2—atopic dermatitis	0.000256	0.0015	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CCR5—atopic dermatitis	0.000254	0.00149	CbGpPWpGaD
Epoprostenol—Pruritus—Prednisone—atopic dermatitis	0.000253	0.000338	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—CCR3—atopic dermatitis	0.000252	0.00148	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCR3—atopic dermatitis	0.000252	0.00148	CbGpPWpGaD
Epoprostenol—Diarrhoea—Prednisone—atopic dermatitis	0.000245	0.000327	CcSEcCtD
Epoprostenol—Nausea—Betamethasone—atopic dermatitis	0.000244	0.000326	CcSEcCtD
Epoprostenol—Nausea—Dexamethasone—atopic dermatitis	0.000244	0.000326	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—TAC1—atopic dermatitis	0.000244	0.00144	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NPS—atopic dermatitis	0.000244	0.00144	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000242	0.00142	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCR3—atopic dermatitis	0.000239	0.00141	CbGpPWpGaD
Epoprostenol—Dizziness—Prednisone—atopic dermatitis	0.000237	0.000316	CcSEcCtD
Epoprostenol—PTGIR—Hemostasis—IL2—atopic dermatitis	0.000235	0.00138	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CCR5—atopic dermatitis	0.000234	0.00138	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CCR5—atopic dermatitis	0.000234	0.00138	CbGpPWpGaD
Epoprostenol—Vomiting—Prednisone—atopic dermatitis	0.000228	0.000304	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—IL5—atopic dermatitis	0.000227	0.00133	CbGpPWpGaD
Epoprostenol—Rash—Prednisone—atopic dermatitis	0.000226	0.000301	CcSEcCtD
Epoprostenol—Dermatitis—Prednisone—atopic dermatitis	0.000226	0.000301	CcSEcCtD
Epoprostenol—PTGER1—Signaling Pathways—TAC1—atopic dermatitis	0.000225	0.00132	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NPS—atopic dermatitis	0.000225	0.00132	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TAC1—atopic dermatitis	0.000225	0.00132	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NPS—atopic dermatitis	0.000225	0.00132	CbGpPWpGaD
Epoprostenol—Headache—Prednisone—atopic dermatitis	0.000224	0.000299	CcSEcCtD
Epoprostenol—PTGIR—Signaling Pathways—CXCR3—atopic dermatitis	0.00022	0.0013	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCR3—atopic dermatitis	0.00022	0.0013	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PPARA—atopic dermatitis	0.000216	0.00127	CbGpPWpGaD
Epoprostenol—Nausea—Prednisone—atopic dermatitis	0.000213	0.000284	CcSEcCtD
Epoprostenol—PTGIR—Signaling Pathways—IL5—atopic dermatitis	0.000209	0.00123	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL5—atopic dermatitis	0.000209	0.00123	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL10—atopic dermatitis	0.000193	0.00114	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL10—atopic dermatitis	0.000178	0.00105	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL10—atopic dermatitis	0.000178	0.00105	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—CD4—atopic dermatitis	0.000169	0.000995	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000169	0.000995	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL5—atopic dermatitis	0.000166	0.00098	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—IL2—atopic dermatitis	0.000162	0.000951	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000156	0.000916	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000156	0.000916	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NGF—atopic dermatitis	0.000154	0.000907	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—CXCL8—atopic dermatitis	0.000153	0.000903	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL5—atopic dermatitis	0.000153	0.000902	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCL5—atopic dermatitis	0.000153	0.000902	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCR5—atopic dermatitis	0.00015	0.000883	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—IL2—atopic dermatitis	0.000149	0.000875	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—IL2—atopic dermatitis	0.000149	0.000875	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL2—atopic dermatitis	0.000147	0.000863	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NGF—atopic dermatitis	0.000142	0.000835	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NGF—atopic dermatitis	0.000142	0.000835	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—CXCL8—atopic dermatitis	0.000141	0.000831	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000141	0.000831	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCR5—atopic dermatitis	0.000138	0.000812	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCR5—atopic dermatitis	0.000138	0.000812	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL2—atopic dermatitis	0.000135	0.000795	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL2—atopic dermatitis	0.000135	0.000795	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NFKBIA—atopic dermatitis	0.000127	0.000748	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NFKBIA—atopic dermatitis	0.000117	0.000689	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000117	0.000689	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GLB1—atopic dermatitis	0.000108	0.000634	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADSL—atopic dermatitis	0.000103	0.000607	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6—atopic dermatitis	9.15e-05	0.000538	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CXCL8—atopic dermatitis	9.07e-05	0.000534	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL2—atopic dermatitis	8.67e-05	0.00051	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6—atopic dermatitis	8.62e-05	0.000507	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CXCL8—atopic dermatitis	8.34e-05	0.000491	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CXCL8—atopic dermatitis	8.34e-05	0.000491	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MAPK8—atopic dermatitis	7.98e-05	0.000469	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL2—atopic dermatitis	7.97e-05	0.000469	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL2—atopic dermatitis	7.97e-05	0.000469	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6—atopic dermatitis	7.93e-05	0.000467	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6—atopic dermatitis	7.93e-05	0.000467	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	7.84e-05	0.000462	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MAPK8—atopic dermatitis	7.34e-05	0.000432	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MAPK8—atopic dermatitis	7.34e-05	0.000432	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6—atopic dermatitis	5.09e-05	0.0003	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6—atopic dermatitis	4.69e-05	0.000276	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6—atopic dermatitis	4.69e-05	0.000276	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARA—atopic dermatitis	3.49e-05	0.000206	CbGpPWpGaD
